261 related articles for article (PubMed ID: 30910753)
1. Automated Volumetric Analysis of Postoperative Magnetic Resonance Imaging Predicts Survival in Patients with Glioblastoma.
Krivoshapkin AL; Sergeev GS; Gaytan AS; Kalneus LE; Kurbatov VP; Abdullaev OA; Salim N; Bulanov DV; Simonovich AE
World Neurosurg; 2019 Jun; 126():e1510-e1517. PubMed ID: 30910753
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
3. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
5. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
7. Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma.
Garcia-Ruiz A; Naval-Baudin P; Ligero M; Pons-Escoda A; Bruna J; Plans G; Calvo N; Cos M; Majós C; Perez-Lopez R
Sci Rep; 2021 Jan; 11(1):695. PubMed ID: 33436737
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Charni S; Cohen-Jonathan-Moyal E; Roux FE
Clin Neurol Neurosurg; 2020 Sep; 196():105972. PubMed ID: 32512407
[TBL] [Abstract][Full Text] [Related]
9. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
11. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
14. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
[TBL] [Abstract][Full Text] [Related]
15. Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.
De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Cohen-Jonathan-Moyal E; Roux FE
J Neurooncol; 2019 May; 142(3):489-497. PubMed ID: 30783874
[TBL] [Abstract][Full Text] [Related]
16. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
[TBL] [Abstract][Full Text] [Related]
17. Patterns and Time Dependence of Unspecific Enhancement in Postoperative Magnetic Resonance Imaging After Glioblastoma Resection.
Bette S; Gempt J; Huber T; Boeckh-Behrens T; Ringel F; Meyer B; Zimmer C; Kirschke JS
World Neurosurg; 2016 Jun; 90():440-447. PubMed ID: 27001238
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
[TBL] [Abstract][Full Text] [Related]
19. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
[TBL] [Abstract][Full Text] [Related]
20. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]